What is Actoprobe?
Founded in 2009 and headquartered in Albuquerque, New Mexico, Actoprobe designs and sells sophisticated optical spectroscopy and microscopy instruments tailored for scanning probe microscopy applications. The company's offerings are crucial for researchers and developers requiring high-precision analytical tools in fields such as materials science, nanotechnology, and biotechnology. Actoprobe's commitment to innovation in photonics and advanced imaging positions it as a key player in the scientific instrument market, enabling breakthroughs through enhanced visualization and measurement capabilities.
How much funding has Actoprobe raised?
Actoprobe has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
What's next for Actoprobe?
With substantial expansion capital now available, Actoprobe is poised to accelerate its product development roadmap and scale its market reach. This strategic financing is expected to fuel advancements in its core spectroscopy and microscopy technologies, potentially leading to new product lines or enhanced features for existing instruments. The company's focus on serving demanding research and development sectors suggests a trajectory aimed at capturing a larger share of the high-value scientific equipment market, reinforcing its position as a leader in specialized optical instrumentation.
See full Actoprobe company page
